BUZZ-Valeant draws options bulls on news of rejected takeover bid
** Trading activity in Valeant Pharmaceuticals International Inc's options busy and sentiment leans bullish as the troubled Canadian drugmaker's U.S.-listed shares jump 9 percent
** Valeant received a joint takeover offer from Japan's Takeda Pharmaceutical Co Ltd and TPG Capital Management LP a month or two ago, but it rejected the offer, Reuters reports on Thursday, citing a source familiar with matter
** On Friday, calls outnumbered puts 1.7x; about 55,000 calls traded, 2x the normal pace, according to Trade Alert data
** VRX 5/27 weekly calls at strike prices 30 & 29 the most heavily traded VRX contracts
** Valeant shares are down about 70 pct this year; shares last up 7 pct to $28.88
© Thomson Reuters 2017 All rights reserved.